Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
INDAPAMIDE
TEVA CANADA LIMITED
C03BA11
INDAPAMIDE
2.5MG
TABLET
INDAPAMIDE 2.5MG
ORAL
30/100
Prescription
THIAZIDE-LIKE DIURETICS
Active ingredient group (AIG) number: 0115402001; AHFS:
CANCELLED PRE MARKET
2015-08-06
PRODUCT MONOGRAPH NTP-INDAPAMIDE (Indapamide) Tablets USP Diuretic/Antihypertensive Agent Teva Canada Limited 30 Novopharm Court Toronto, Ontario Canada, M1B 2K9 Submission Control No: 167238 Date of Preparation: August 28, 2013 1 PRODUCT MONOGRAPH NTP-INDAPAMIDE (Indapamide) Tablets USP THERAPEUTIC CLASSIFICATION Diuretic/Antihypertensive Agent ACTION AND CLINICAL PHARMACOLOGY Indapamide is a diuretic antihypertensive agent. The mechanism whereby indapamide exerts its action in the control of hypertension is not completely elucidated: both renal and extrarenal actions may be involved. The renal site of action is the proximal part of the distal tubule and the ascending part of Henle's loop. Sodium and chloride ions are excreted in approximately equivalent amounts. The increased delivery of sodium to the distal tubular exchange site results in increased potassium excretion and hypokalemia. Pharmacokinetics: Indapamide is rapidly and completely absorbed after oral administration. Peak blood levels are obtained after 1 to 2 hours. Indapamide is concentrated in the erythrocytes and is 79% bound to plasma proteins and to erythrocytes. 2 It is taken up by the vascular wall in smooth vascular muscle according to its high lipid solubility. Seventy per cent of a single oral dose is eliminated by the kidneys and 23% by the gastrointestinal tract. Indapamide is metabolized to a marked degree, the unchanged product representing approximately 5% of the total dose found in the urine during the 48 hours following administration. Elimination of indapamide from the plasma is biphasic with half-lives of 14 and 25 hours respectively. A comparative two-way, single-dose bioavailability study was performed between NTP- INDAPAMIDE (indapamide) 2.5 mg Tablets and Lozide ® (indapamide) 2.5 mg Tablets. The pharmacokinetic plasma data calculated for the two formulations are tabulated below: Geometric Mean Arithmetic Mean (C.V.) Parameter NTP-INDAPAMIDE (2 x 2.5 mg) Lozide ® ** (2 x 2.5 mg) Percentage of Lozide ® AUCT (ngh/mL) 3374 3545 Baca dokumen lengkap